Walgreens concealed from investors that growth in its US health-care segment was slower than expected because it oversaturated markets with VillageMD clinics, the complaint, filed Tuesday in the US District Court for the Northern District of Illinois, said.
The oversaturation led “these newly created medical clinics to be understaffed, have less patients coming in to be treated, and culminating in a greater than expected impact on Company’s ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.